To See The Effect Of Sitopaladi Churna And Its Modified Dosage Form Lozenges On Kasa (Dry Cough)

DEVELOPMENT OF A NEW DOSAGE FORM "LOZENGES" FROM THE CONTENTS OF THE SITOPALADI CHURNA BY DIFFERENT METHODS AND ITS COMPARATIVE PHARMACEUTICAL, ANALYTICAL, STABILITY AND PILOT STUDY OF BOTH DOSAGE FORMS ON KASA (DRY COUGH) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084060

Enrollment

Registered

2025-04-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R05- Cough

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having classical features of kasa. Patients having cough without sputum.

Exclusion criteria

Exclusion criteria: Patients below the age of 20 years and above the age of 50 years. Patients having kasa as a complication of other systemic disease. Patients suffering from any lower respiratory tract infection like pneumonia, bronchial asthma etc. Patients suffering from tuberculosis, HIV, SLE, respiratory failure, CHF. Patients having Kasa associated with chest injuries, hemoptysis and bronchial carcinoma.

Design outcomes

Primary

Measure	Time frame
To develop the lozenges which is of good consistency with good stability and efficacy. Timepoint: The patient will be assessed at 7th and 14th day of the treatment.	—

Secondary

Measure	Time frame
To assess whether the lozenges are equally, more or less effective than the sitopaladi churna in the patients of kasa.Timepoint: The patient will be assessed at 7th & 14th day of the treatment.	—

Countries

India

Contacts

Public ContactDR POOJA

Institute For Ayurved Studies And Research

raviraz@gmail.com7988499972

Outcome results